The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
As the GameFi sector enters its next phase of evolution, the traditional model of relying on a single blockbuster title to sustain an ecosystem is facing rigorous challenges. Today, the high-profile Web3 gaming project RuneSoul set the market ablaze by officially announcing the closing of a $30 million strategic investment round.
This massive capital injection is more than just “fueling the tank”; it serves as a clarion call for the expansion of the RuneSoul ecosystem. Official sources state that the funds will be primarily allocated toward a comprehensive strategic pivot and infrastructure overhaul. RuneSoul is transcending its identity as a standalone 3A ARPG blockchain game to become a full-scale Web3 Gaming Aggregator & Launchpad.
Breaking GameFi Silos: The “Super Connector” of the Industry
The Web3 gaming industry has long struggled with a “supply-demand mismatch”: talented developers often lack Web3 publishing expertise, while token holders and large-scale guilds are starved for high-quality, sustainable content.
RuneSoul’s transformation aims to fill this market vacuum by positioning itself as a definitive Connector:
Supply Side: Providing traditional game studios and Web3 developers with low-barrier “blockchain-integration” gateways, solving technical hurdles and complex economic model design.
Demand Side: Aggregating global players, top-tier guilds, and distribution channels to tackle the challenges of fragmented traffic and skyrocketing user acquisition costs.
A One-Stop Full-Stack Solution: Building an Ecological Moat
Unlike standard launchpads that offer limited “listing” or “NFT sale” functions, RuneSoul’s “Web3 Gaming Full Lifecycle Solution” is far more ambitious and execution-focused. 9The platform will deliver core services across five key dimensions:
Issuance: Facilitating initial asset offerings (INO/IDO) based on proven tokenomic models.
Growth & Incentive: Leveraging SocialFi mechanisms for viral growth and precision user matching, supported by multi-tiered incentive systems for player retention.
Asset Management: Offering secure, user-friendly built-in wallets and a marketplace to bridge asset barriers between different games.
On-chain Data: Tracking real-time behavior to provide developer user-personas and investor decision-making tools.
Settlement System: An efficient on-chain settlement layer ensuring all revenues are transparent and settled instantly.
From GameFi 4.0 to Industry Infrastructure
At its inception, RuneSoul introduced the concept of GameFi 4.0, emphasizing the deep integration of gameplay and social utility. With this $30M infusion, RuneSoul is now scaling this philosophy from a “single game” to an “entire ecosystem.”
This pivot leverages RuneSoul’s track record—including the successful launch of $RST, high-fidelity graphics, and a robust community—to incubate a new wave of high-quality titles.
“If Steam is the lighthouse of Web2 gaming, RuneSoul aspires to be the gateway for Web3 gaming,” stated the core team. This $30 million investment is not only a validation of RuneSoul’s past performance but a high-stakes bet on its “platform-centric” future.
Silver reached $77 per ounce, recovering slightly after a dramatic “flash crash” that saw prices plunge from $84 to below $73 in a single session. Analysts link the decline to a major bank liquidation, rumored to be UBS, and a margin increase by the CME Group. Despite this, silver’s long-term outlook remains bullish due to industrial demand in solar panels, electronics, and the upcoming Chinese export restrictions.
Copper prices are currently around $5.51–$5.80 per pound. The metal has experienced a volatile end to the year but remains up 36% year-over-year. Growth in electrification, AI data center expansion, and green energy infrastructure have fueled strong demand. Supply disruptions in Indonesia and Chile, combined with worker protests in Peru, have tightened global availability, contributing to copper’s 2025 rally.
Gold has traded in a narrow range above $4,300, reflecting moderate easing by the Fed and inflation dynamics. Prices ranged from $4,323.80 to $4,403.90 in the final days of December, closing at $4,400, a 1.58% increase over recent sessions. Market analysts note that central bank purchases and continued safe-haven interest will likely support gold in 2026, with projections from Goldman Sachs and UBS pointing toward $5,000 per ounce.
Investor sentiment has also been influenced by a softer U.S. dollar, which makes gold cheaper for holders of other currencies. Geopolitical tensions and year-end portfolio rebalancing have added momentum, encouraging traders to maintain positions in gold. Overall, gold remains a key hedge against inflation and economic uncertainty heading into 2026.
Silver experienced extreme volatility between December 29–30, dropping from $84 to below $73 per ounce. The sudden decline followed a major bank liquidation and a margin hike on CME silver contracts. Prices have since stabilized near $75–$77. Investors are closely watching China’s new silver export licensing rules, effective January 1, 2026. As the world’s dominant silver processor, China’s policy is expected to tighten global supply, a key factor behind silver’s record-breaking rally earlier this month.
The industrial demand for silver, particularly in solar panels, electronics, and electric vehicles, continues to underpin its value. Analysts highlight that the supply-demand imbalance could persist for months, making silver a potential outperformer in 2026. Market watchers are also noting increased interest from investment funds, which may further amplify price movements.
Copper ended 2025 near $5.6787 per pound, up 2.59% over the last trading session and 36% for the year. Demand is being driven by AI infrastructure, data center buildouts, and global green energy transitions. Supply-side risks remain significant, with halted operations at Freeport-McMoRan’s Grasberg mine in Indonesia, responsible for 3% of global output, and labor unrest in Chile and Peru. Recent threats of US tariffs on copper commodity forms have also shifted flows into US warehouses, tightening markets further.
Long-term demand for copper is expected to strengthen as countries accelerate electrification projects and renewable energy installations. Analysts point to rising copper intensity in electric vehicles, wind turbines, and battery storage as a structural support for prices. The market is likely to remain sensitive to production disruptions, making copper a high-interest commodity for 2026 investors.
Analysts remain bullish for 2026. Gold is expected to continue as a safe-haven asset amid global uncertainties. Silver may test $100 per ounce due to supply deficits and industrial demand. Copper’s outlook is supported by governments’ electrification agendas and rising capital expenditure in AI and clean energy sectors. Investors are closely monitoring both geopolitical developments and supply disruptions as metals enter the new year with strong momentum.
Experts also emphasize the role of central banks, particularly in emerging markets, as continued buyers of gold and silver. Policy shifts, export controls, and infrastructure spending in green technology could create new volatility and opportunities across all three metals. Overall, metals are positioned for strong performance, but investors should prepare for occasional price swings.
As 2025 closes, gold near $4,400, silver around $77, and copper above $5.60 reflect not just cyclical momentum, but deeper structural shifts. Entering 2026, investors are watching whether these forces intensify—or collide—setting the stage for another defining year in global commodities markets.
Q: Why did silver experience a sharp drop at the end of December 2025? A: Silver plunged from $84 to below $73 on December 29–30 due to a major bank liquidation and a CME Group margin hike. The move caused short-term volatility but prices stabilized near $75–$77. China’s upcoming export licensing rules may continue to influence supply and price.
Q: What factors are driving copper and gold prices heading into 2026?
A: Copper remains strong at $5.68 per pound, supported by AI infrastructure, data centers, and green energy demand. Gold trades above $4,400 due to Fed rate cuts, safe-haven buying, and geopolitical tensions. Supply disruptions in Indonesia, Chile, and Peru further tighten global markets. Analysts forecast higher metals prices in 2026.
Marks & Spencer is launching a range of foods tailored to people taking weight-loss injections as use of the drugs accelerates in the UK.
The new range of 20 “nutrient-dense” products from the retailer is aimed at customers taking GLP-1 weight-loss medications, as supermarkets increasingly adapt to the impact the drugs are having on shopping baskets.
The range will go on sale in M&S foodhalls from January 5 and includes salads, meals and bread designed to deliver high levels of fibre, vitamins and minerals in smaller portions.
There has been a dramatic rise in the use of GLP-1 drugs in the UK. Online searches and private prescriptions have increased sharply, driven by their effectiveness for weight loss and widespread media attention. About 1.5 million people in the UK are now estimated to be accessing GLP-1 treatment privately, while NHS England prescriptions for the injections have risen by around 900 per cent since 2020.
GLP-1 medications — known formally as glucagon-like peptide-1 (GLP-1) receptor agonists — were originally developed to treat type 2 diabetes by helping to regulate blood sugar. In recent years, drugs such as semaglutide (sold as Ozempic for diabetes and Wegovy for weight loss) and tirzepatide (sold as Mounjaro) have surged in popularity for their weight-loss effects, as they suppress appetite, slow digestion and signal fullness to the brain.
• Our writers’ share tips for 2026, plus last year’s winners and losers
Nutrient-dense foods are those that provide a concentrated source of vitamins, minerals, fibre, healthy fats and protein relative to their calorie content. M&S said the range was developed by its nutritionists in consultation with the British Nutrition Foundation, using criteria that ensure each product delivers more nutrients per mouthful.
M&S said the new range had been developed to address the nutritional challenges that can arise when people eat less, whether due to medication, age or lifestyle. A reduced appetite can make it harder to consume enough fibre and essential nutrients, increasing the risk of deficiencies and digestive side effects such as constipation.
Grace Ricotti, M&S head of food nutrition, said: “Our nutrient-dense range is perfect for customers looking to support their health as each recipe is packed with the key nutrients we all need in our diets.
“With the increase in popularity of weight-loss injections, a reduced appetite can mean missing out on important nutrients and that’s why nutrient density is so important.
“These new meals, snacks and drinks can help everyone get more fibre, vitamins and minerals in their diet.”
Supermarkets and consumer goods companies are increasingly catering to households using the drugs. Morrisons was the first UK supermarket to announce a dedicated “GLP-1 friendly” range, developed with sports nutrition brand Applied Nutrition, under its “Small & Balanced” banner. Nestlé, the consumer goods giant, has launched a frozen food brand in the US aimed at GLP-1 users, while Haleon, the British multinational consumer healthcare company, has introduced a multivitamin designed to help replenish nutrients for people eating less.
The trend is expected to accelerate further as GLP-1 medications move beyond injections. Tablet versions are beginning to reach the market, with US regulators approving an oral version of Wegovy and rival pills expected to follow, potentially widening access to the drugs.
While the drugs are approved for diabetes and obesity treatment, clinicians have raised concerns about the number of people accessing them outside clinical pathways for cosmetic weight loss. The long-term consequences of widespread use are still being studied, particularly as lower calorie intake can increase the risk of nutrient deficiencies if diets are not carefully managed.
Silver (XAG/USD) is trimming losses on Tuesday after depreciating beyond 7% amid Monday’s thin liquidity conditions. The escalating tensions in diverse regions of the world, coupled with market expectations that the Fed minutes will cement hopes of further monetary easing in 2026, are providing support to precious metals on Tuesday.
Moscow announced the revision of its stance on the peace talks with Ukraine after an alleged drone attack on one of President Vladimir Putin’s residences, while in the South East China Sea, military drills around Taiwan extend for the second day. Beyond that, US President Trump has threatened another attack on Iran.
Apart from that, the minutes of the last Federal Reserve meeting, due later today, are expected to reflect a wide divergence within the monetary policy committee, and feed hopes that the bank might lower borrowing costs beyond the 25 basis pòints projected in the Dot Plot.
In the 4-hour chart, XAG/USD trades at $75.65, after having bottomed at $70.53 on Monday. The rising 50-period Simple Moving Average (SMA), near $70.89, held bears on Monday and keeps the broader upside trend in play.
Oscillators, however, are mixed. The Moving Average Convergence Divergence (MACD) line remains below the Signal line and under the zero mark, while the Relative Strength Index (RSI) has returned to bullish territory above the key 50 line.
The bearish engulfing pattern in the daily chart is a negative sign that might anticipate a deeper correction. Resistances are at the $76.50 intra-day level, ahead of the $80.00 psychological level and the all-time high, at $85.87.
On the downside, the mentioned 50-period SMA and Monday’s low at $70.53 are likely to provide support on a potential bearish reversal. Further down, the December 18 low, near $64.75, will come into focus.
(The technical analysis of this story was written with the help of an AI tool)
Silver is a precious metal highly traded among investors. It has been historically used as a store of value and a medium of exchange. Although less popular than Gold, traders may turn to Silver to diversify their investment portfolio, for its intrinsic value or as a potential hedge during high-inflation periods. Investors can buy physical Silver, in coins or in bars, or trade it through vehicles such as Exchange Traded Funds, which track its price on international markets.
Silver prices can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can make Silver price escalate due to its safe-haven status, although to a lesser extent than Gold’s. As a yieldless asset, Silver tends to rise with lower interest rates. Its moves also depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAG/USD). A strong Dollar tends to keep the price of Silver at bay, whereas a weaker Dollar is likely to propel prices up. Other factors such as investment demand, mining supply – Silver is much more abundant than Gold – and recycling rates can also affect prices.
Silver is widely used in industry, particularly in sectors such as electronics or solar energy, as it has one of the highest electric conductivity of all metals – more than Copper and Gold. A surge in demand can increase prices, while a decline tends to lower them. Dynamics in the US, Chinese and Indian economies can also contribute to price swings: for the US and particularly China, their big industrial sectors use Silver in various processes; in India, consumers’ demand for the precious metal for jewellery also plays a key role in setting prices.
Silver prices tend to follow Gold’s moves. When Gold prices rise, Silver typically follows suit, as their status as safe-haven assets is similar. The Gold/Silver ratio, which shows the number of ounces of Silver needed to equal the value of one ounce of Gold, may help to determine the relative valuation between both metals. Some investors may consider a high ratio as an indicator that Silver is undervalued, or Gold is overvalued. On the contrary, a low ratio might suggest that Gold is undervalued relative to Silver.
Japan’s tea giant Ito En is sneaking into US fridges and investor watchlists. Viral matcha, steady stock, real talk: is this a low-key game-changer or just background noise?
The internet is slowly waking up to Ito En Ltd – the Japanese tea giant behind a ton of the green tea bottles you see in Asian markets and some US grocery chains. But here’s the question you actually care about: is Ito En worth your money – as a drink and as a stock – or is it just background noise in your portfolio?
You’ve seen matcha everywhere, you’ve seen green tea pushed as a “healthy energy” swap, and you’ve probably scrolled past at least one creator talking about Japanese convenience-store drinks. But is Ito En the real quiet flex here, or are you better off grabbing a random store brand and calling it a day? Let’s break the hype.
On social, Ito En isn’t blowing up the way Prime or Celsius do, but it’s got that “if you know, you know” cult status. Wellness creators, J-beauty stans, and anime-core shoppers are all quietly boosting it.
Want to see the receipts? Check the latest reviews here:
Social sentiment? It’s not “everyone’s screaming in the comments” viral, but it’s definitely in “must-cop if you’re into Japanese drinks, matcha, or ‘cleaner’ caffeine” territory. People shout out:
The clout level isn’t chaotic, but it’s solid and growing – especially as Asian snacks, K/J-beauty, and Tokyo travel vlogs keep flooding feeds.
So, zoom in: as a product and as a stock, is it worth the hype? Here’s the real talk, boiled down to three big points.
Ito En’s core flex is simple: it tastes like actual tea. Their flagship green tea bottles are lighter, less sweet, and way closer to what you’d actually drink in Japan. For you, that means:
It’s not a shock-value drink. It’s more like that friend who’s always in the gym, never posting about it, but still shredded. Understated, but real.
Now let’s talk about Ito En as a company – ticker linked to ISIN JP3143600009, trading on the Tokyo market.
Data check (real-time note): Using live market tools, the latest available data for Ito En stock shows the most recent trading info as follows:
At the time of checking, markets were not actively trading, so pricing is based on the last close rather than live ticks. The exact price can move, and you should always refresh a live finance site before you buy.
What actually matters for you:
If you want pure chaos and 3X risk, skip. If you want a slow-burn, real-business company in a category that keeps getting trendier (wellness drinks, functional beverages, Japanese imports), Ito En starts looking like a no-brainer for the cautious corner of your portfolio.
This is where Ito En quietly wins. The brand taps into three big waves:
That combo makes it extremely future-proof for clout. Even if it never turns into an energy-drink-level craze, it’ll likely stay “respected and recommended” in wellness and foodie circles.
So who’s the real rival here? In the US, you’re basically choosing between:
On clout, here’s how it shakes out:
If we’re talking pure clout war for your feed right now, energy drinks still win the viral race. They’re louder, crazier, more meme-able.
But if we’re talking long-term relevance – something you’d actually still be drinking and maybe investing in years from now – Ito En quietly comes out ahead. It’s the kind of brand that can live in supermarkets, convenience stores, cafe menus, and your fridge without needing a scandal or stunt every month.
So, real talk: is Ito En a must-have or an overhyped import?
As a drink:
As a stock:
Is it a game-changer? Not in the “world flipping overnight” sense. But in the “this is a legit, durable brand that fits where the culture is heading” sense – it’s closer to a quiet game-changer than a flop.
If you’re trying to mix vibes + health + actual business fundamentals, Ito En deserves at least a spot on your watchlist – and maybe in your fridge while you think about it.
Let’s zoom out and hit the finance notes you actually need.
Company: Ito En Ltd
ISIN: JP3143600009
Listing: Tokyo Stock Exchange (common code often shown as 2593.T on US finance apps)
Stock data status: Using live financial data tools, the latest available figures are based on the last market close, confirmed across at least two reputable sources (such as Yahoo Finance and another major financial outlet). Because markets are not always open while you are reading this, you should refresh a live chart before making any moves.
Key takeaways on the business side:
How to approach it:
Bottom line: Ito En is not screaming for attention – but that might be exactly why it belongs on the radar of anyone who likes their investments like their drinks: clean, dependable, and a little bit underrated.
XRP is navigating a delicate consolidation phase as traders balance improving macro liquidity conditions against unresolved technical resistance, leaving the market poised for a potential momentum shift.
The XRP price today remains confined to a narrow range, reflecting cautious positioning after recent volatility. This type of compression has been a recurring feature in XRP’s historical price behavior, where extended consolidations near higher-timeframe support often persist until volume expansion provides clearer directional confirmation.
Recent price behavior shows XRP consolidating just below a key technical threshold. On the monthly XRP price chart, analyst ChartNerd (@ChartNerdTA) identified $1.889 as a critical support level, a zone that closely aligns with a former range high and a high-volume node from prior trading cycles.
XRP hovers in consolidation as bulls await a confirmed technical green light before the next decisive move. Source: @ChartNerdTA via X
“$XRP: Waiting for a green light,” ChartNerd wrote, explaining that sustained acceptance above this level could reopen upside toward $3, while a failure to hold may expose a deeper retracement toward the $1 region. The significance of this zone lies less in the level itself and more in how price behaves around it, particularly whether buyers are willing to absorb sell pressure on higher timeframes.
XRP’s brief dip toward $1.85 reinforced the importance of this support band. The analyst reiterated an earlier December outlook, emphasizing patience and confirmation before positioning aggressively. Rising exchange inflows were cited as a near-term risk factor, as historically, similar inflow spikes have coincided with distribution phases rather than immediate breakouts.
From a shorter-term perspective, TradingView analyst subhikarkar55, who focuses on intraday and swing-level structure, outlined a potential recovery path. According to the analyst, XRP must first reclaim $1.88, a level that previously acted as short-term value support, to stabilize momentum.

XRP at $1.8516 eyes a rebound to $1.88, with a potential move toward $1.9213 if resistance is broken. Source: subhikarkar55 on TradingView
“Recent price at $1.8516 suggests a rebound toward $1.8800,” the analyst noted, adding that a clean move above this area could open a test of $1.9213. Technically, the $1.92 zone corresponds with the upper boundary of XRP’s recent value area, where prior advances stalled amid weakening spot volume.
As a result, analysts increasingly view this level as a confirmation threshold rather than a breakout target. A sustained close above $1.92, supported by rising spot participation rather than derivatives-led momentum, would carry more analytical weight than a brief intraday spike.
Beyond chart structure, macro liquidity developments have drawn attention. Market commentator Amonyx (@amonyx) pointed to a recent Federal Reserve repo operation, stating that the Fed injected $29.5 billion into the financial system in late December.

The Fed injects $29.5B into the economy, sparking bullish momentum for XRP. Source: @amonyx via X
Official data, however, shows accepted repo amounts closer to $25.45 billion, primarily across Treasury, agency, and mortgage-backed securities. Similar year-end operations in previous months have approached the higher figure, reflecting routine balance-sheet management rather than a targeted stimulus for risk assets.
While such liquidity measures can indirectly support broader market stability, historical data suggests XRP’s correlation with short-term repo operations has been inconsistent. In prior year-end liquidity events, XRP price responses have depended more on prevailing risk sentiment and internal market structure than on liquidity injections alone.
XRP remains in a compression phase, with price action reflecting a balance between technical caution and modest macro tailwinds. While Federal Reserve liquidity operations may help stabilize broader financial conditions, analysts continue to emphasize that XRP’s next move hinges on technical confirmation, not narrative catalysts.

XRP was trading at around 1.86, up 0.22% in the last 24 hours at press time. Source: XRP price via Brave New Coin
For short-term traders, a high-volume close above $1.92 would serve as the clearest signal of improving momentum. For longer-term participants, the ability of XRP to hold above the $1.88–$1.89 support zone may matter more than short-term volatility. Until those conditions are met, market behavior suggests participants remain disciplined, prioritizing structure and confirmation over anticipation.
Marks & Spencer is launching a range of foods tailored to people taking weight-loss injections as use of the drugs accelerates in the UK.
The new range of 20 “nutrient-dense” products from the retailer is aimed at customers taking GLP-1 weight-loss medications, as supermarkets increasingly adapt to the impact the drugs are having on shopping baskets.
The range will go on sale in M&S foodhalls from January 5 and includes salads, meals and bread designed to deliver high levels of fibre, vitamins and minerals in smaller portions.
There has been a dramatic rise in the use of GLP-1 drugs in the UK. Online searches and private prescriptions have increased sharply, driven by their effectiveness for weight loss and widespread media attention. About 1.5 million people in the UK are now estimated to be accessing GLP-1 treatment privately, while NHS England prescriptions for the injections have risen by around 900 per cent since 2020.
GLP-1 medications — known formally as glucagon-like peptide-1 (GLP-1) receptor agonists — were originally developed to treat type 2 diabetes by helping to regulate blood sugar. In recent years, drugs such as semaglutide (sold as Ozempic for diabetes and Wegovy for weight loss) and tirzepatide (sold as Mounjaro) have surged in popularity for their weight-loss effects, as they suppress appetite, slow digestion and signal fullness to the brain.
• Our writers’ share tips for 2026, plus last year’s winners and losers
Nutrient-dense foods are those that provide a concentrated source of vitamins, minerals, fibre, healthy fats and protein relative to their calorie content. M&S said the range was developed by its nutritionists in consultation with the British Nutrition Foundation, using criteria that ensure each product delivers more nutrients per mouthful.
M&S said the new range had been developed to address the nutritional challenges that can arise when people eat less, whether due to medication, age or lifestyle. A reduced appetite can make it harder to consume enough fibre and essential nutrients, increasing the risk of deficiencies and digestive side effects such as constipation.
Grace Ricotti, M&S head of food nutrition, said: “Our nutrient-dense range is perfect for customers looking to support their health as each recipe is packed with the key nutrients we all need in our diets.
“With the increase in popularity of weight-loss injections, a reduced appetite can mean missing out on important nutrients and that’s why nutrient density is so important.
“These new meals, snacks and drinks can help everyone get more fibre, vitamins and minerals in their diet.”
Supermarkets and consumer goods companies are increasingly catering to households using the drugs. Morrisons was the first UK supermarket to announce a dedicated “GLP-1 friendly” range, developed with sports nutrition brand Applied Nutrition, under its “Small & Balanced” banner. Nestlé, the consumer goods giant, has launched a frozen food brand in the US aimed at GLP-1 users, while Haleon, the British multinational consumer healthcare company, has introduced a multivitamin designed to help replenish nutrients for people eating less.
The trend is expected to accelerate further as GLP-1 medications move beyond injections. Tablet versions are beginning to reach the market, with US regulators approving an oral version of Wegovy and rival pills expected to follow, potentially widening access to the drugs.
While the drugs are approved for diabetes and obesity treatment, clinicians have raised concerns about the number of people accessing them outside clinical pathways for cosmetic weight loss. The long-term consequences of widespread use are still being studied, particularly as lower calorie intake can increase the risk of nutrient deficiencies if diets are not carefully managed.
BNB price today sits at a critical point for Australian traders. We track BNBUSD as BSC activity cools and futures interest softens. A bearish pennant points to a possible retest of $700 unless price regains $945. Yet trend strength and 2025 adoption highs keep a move toward $989 in play. For AU-based investors, these USD levels guide local AUD pairs, spreads, and timing into the New Year’s session.
BNB price today faces pressure as core network usage slows. A key BSC metric reportedly plunged about 80%, signaling thinner on-chain demand and lower fee burn. That weakens upside momentum and raises drawdown odds. See the network data context here: CoinGape. With lighter activity, sellers can test supports faster, keeping $700 in view.
BNB price today also reflects a softer derivatives backdrop. Lower open interest often means smaller liquidity pockets and sharper moves around stops. If spot bids fade near prior supports, bears can press price toward the measured move of the pennant. Until liquidity returns, any bounce may struggle unless buyers defend higher lows above $900.
Despite near-term risk, BNB price today still holds a bullish pathway. Our recent analysis flagged strong trend readings and improving volume on rallies, supporting a move toward $989.62 when momentum aligns. If buyers keep daily closes above higher supports and pullbacks are shallow, dip demand can reset the trend and squeeze shorts into late-session strength.
BNB price today benefits from broader network adoption. In 2025, BNB hit a 279 million milestone, highlighting growing user reach and developer pull. Larger ecosystems tend to smooth volatility over time and attract liquidity during risk-on phases. Read more on the milestone here: AMBCrypto. Adoption can underpin rebounds when technicals turn.
For BNB price today, $945 is the pivot. Reclaiming and holding above it invalidates the bearish pennant and improves odds of a push to $989.62. Failure to close above $945 keeps sellers in control, with $900 and $870 as checkpoints. Loss of those opens room to revisit $820 and, in a worse case, the $700 retest.
BNB price today may see volatility around the Asia open and late US hours, which fall mid-morning to afternoon AEDT. AU traders can track AUD pairs for slippage and use limit orders during thin liquidity. A simple plan: watch for a clean 4-hour close above $945 for longs, or a rejection there for short-biased hedges.
If momentum fades, BNB price today can revisit $900, then $870. A break below $850 raises risk to $820. The pattern’s lower target sits near $700 if selling accelerates on low liquidity. Traders can scale entries near supports and avoid chasing breakdowns, focusing on clear closes and measured risk per trade.
If buyers reclaim $945 with rising volume, BNB price today can target $970 first, then $989 to $989.62. A strong close above $990 sets up $1,020 to $1,050 extension. Look for rising OBV or volume expansion on green candles. Pullbacks to $945 that hold turn the level into support for trend continuation.
For Australian investors, BNB price today hinges on a simple map. Bears control below $945, with $900, $870, and $820 as steps to defend before the riskier $700 area. Bulls need a decisive reclaim and hold above $945, then a push through $970 toward $989 to confirm strength. Use clear levels, not guesses. Plan trades around liquid hours, prefer limit orders on AUD pairs, and size positions so one loss never hurts your week. If $945 flips to support on strong volume, favor trend trades. If it fails, respect downside and wait for a better base.
Two paths dominate. A reclaim and hold above $945 points to $970 and then $989 to $989.62. Failure below $945 keeps pressure on $900, then $870 and $820, with a worst-case $700 retest. Watch 4-hour closes and volume to confirm the break or rejection.
Slower BSC activity can mean fewer on-chain transactions and lower fee burn, which weakens demand. When network usage drops, liquidity thins and price becomes more vulnerable to downside tests. A rebound in activity often supports stronger bids and reduces the chance of sharp pullbacks.
Near term, a clean move above $945 opens $970 and then $989.62. If price cannot hold $945, expect chop and tests of $900, $870, and possibly $820. Use AUD pairs with limit orders, and confirm entries with rising volume or stronger closes to cut false signals.
Define risk first. Track USD levels but execute in AUD pairs where possible. Wait for a 4-hour close above $945 for a long bias, or a rejection there for hedges. Avoid chasing moves during thin liquidity, and keep position sizes small enough to withstand volatility.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes.
Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
Spot Gold tries to regain its bullish poise on Tuesday, trading above $4,350 after bottoming at $4,300 on Monday. The XAU/USD pair edged sharply lower after reaching an all-time high at the beginning of the week amid profit-taking ahead of the New Year’s holiday. The bright metal benefits from a risk-averse environment, although the advance is tepid amid resurgent US Dollar (USD) demand.
Wall Street is under pressure for a second consecutive day, although the slide is more linked to the lack of news than to a negative headline. Pretty much, investors are closing their books for the year as most financial markets will be closed on Wednesday, with market activity resuming on January 2.
A pinch of caution adds to the USD near-term advance ahead of the release of the Federal Open Market Committee (FOMC) minutes of the December meeting. The document will be released in the mid-American session and could shed some light on the next Federal Reserve (Fed) monetary policy steps. The release may trigger near-term movements due to the ongoing lack of trading volume, but is unlikely to have a sustained impact, as market players are patiently waiting for United States (US) President Donald Trump to name the next Chair to go full in.
In the 4-hour chart, XAU/USD trades at $4,358.16 and aims to extend its slide. The 20-period Simple Moving Average (SMA) has turned lower above the current level, providing dynamic resistance at $4,445.70. Still, the 100- and 200-period SMAs remain below spot with modest upward slopes, at $4,339.52 and $4,240.55, respectively. At the same time, the Momentum indicator aims lower below its midline, while the Relative Strength Index (RSI) indicator also aims south at 37, in line with a continued slide.
In the daily chart, however, the downward potential of XAU/USD seems limited. The 20-day SMA continues to provide relevant support at $4,315, while rising above the 100- and 200-day SMAs, which maintain their bullish slopes. The Momentum indicator edges higher above its midline, while the RSI indicator advances at around 56, suggesting buyers paused but did not give up. The broader trend backdrop remains positive as the 100- and 200-day SMAs continue to slope higher, and the bullish tone would persist as long as the price holds above the 20-day SMA at $4,315.
(The technical analysis of this story was written with the help of an AI tool)